BenjaminLi-PingHsuMD

PubMed

• 2 citations
  Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgrou...
  Yoshiya Tanaka, Tsutomu Takeuchi, Masayoshi Harigai, Hisashi Yamanaka, Toshikazu Nakano, Koshiro Akagi, Yoshifumi Ukyo, Benjamin Hsu> ;Modern Rheumatology. 2019 Mar 4
• 9 citations
  Investigating sirukumab for rheumatoid arthritis: 2-year results from the phase III SIRROUND-D study.
  Carter Thorne, Tsutomu Takeuchi, George Athanasios Karpouzas, Shihong Sheng, Regina Kurrasch, K. Fei, Benjamin Hsu> ;RMD Open. 2018 Nov 1
• 18 citations
  Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a rand...
  Peter C. Taylor, Michael Schiff, Qingmin Wang, Yusang Jiang, Yanli Zhuang, Regina Kurrasch, Shruti Daga, Ravi Rao, Paul P. Tak, Benjamin Hsu> ;Annals of the Rheumatic Diseases. 2018 May 1
• 14 citations
  Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients
  Tsutomu Takeuchi, Hisashi Yamanaka, Masayoshi Harigai, Ryo Tamamura, Yuichi Kato, Yoshifumi Ukyo, Toshikazu Nakano, Benjamin Hsu, Yoshiya Tanaka> ;Arthritis Research & Therapy. 2018 Mar 7
• 2 citations
  Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: S...
  Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, Masayoshi Harigai, Toshikazu Nakano, Koshiro Akagi, Yoshifumi Ukyo, Benjamin Hsu> ;Modern Rheumatology. 2018 Feb 7
• 49 citations
  Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study.
  Tsutomu Takeuchi, Carter Thorne, George Karpouzas, Shihong Sheng, W. Xu, Ravi Rao, K. Fei, Benjamin Hsu, Paul P. Tak> ;Annals of the Rheumatic Diseases. 2017 Aug 30
• 24 citations
  Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE...
  Robert D. Inman, Xenofon Baraliakos, Kay-Geert A. Hermann, Juergen Braun, Atul Deodhar, Désirée van der Heijde, Stephen Xu, Benjamin Hsu> ;Arthritis Research & Therapy. 2016 Dec 28
• 26 citations
  Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
  Jonathan Kay, Roy Fleischmann, Edward C. Keystone, Elizabeth C. Hsia, Benjamin Hsu, Yiying Zhou, Neil Goldstein, Jürgen R. Braun> ;The Journal of Rheumatology. 2016 Dec 1
• 27 citations
  Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Tr...
  Jürgen Braun, Xenofon Baraliakos, Kay-Geert A. Hermann, Stephen Xu, Benjamin Hsu> ;The Journal of Rheumatology. 2016 Sep 1
• 67 citations
  Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients w...
  Jonathan Kay, Roy Fleischmann, Edward C. Keystone, Elizabeth C. Hsia, Benjamin Hsu, Michael Mack, Neil Goldstein, Jürgen Braun, Arthur Kavanaugh> ;Annals of the Rheumatic Diseases. 2015 Mar 1
• 88 citations
  The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
  Jürgen Braun, Xenofon Baraliakos, Kay-Geert A. Hermann, Atul Deodhar, Désirée van der Heijde, Robert D. Inman, A. Beutler, Yiying Zhou, Stephen Xu, Benjamin Hsu> ;Annals of the Rheumatic Diseases. 2014 Jun 1
• 38 citations
  The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial
  Désirée van der Heijde, Atul Deodhar, Jürgen Braun, Michael Mack, Benjamin Hsu, T. Gathany, Robert D. Inman, Chenglong Han> ;The Journal of Rheumatology. 2014 Jun 1
• 25 citations
  The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
  Daniel E. Furst, Jonathan Kay, Mary Chester M. Wasko, Edward C. Keystone, Arthur Kavanaugh, Atul Deodhar, Frederick T. Murphy, Jeanette H. Magnus, Elizabeth C. Hsia, B...> ;Rheumatology. 2013 Oct 1
• 16 citations
  Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype.
  Pedro Machado, Robert Landewé, Jürgen Braun, Xenofon Baraliakos, Kay-Geert A. Hermann, Benjamin Hsu, Daniel Baker, Désirée van der Heijde> ;Annals of the Rheumatic Diseases. 2013 Jun 1
• 25 citations
  Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE)
  Désirée van der Heijde, Jurgen Braun, Atul Deodhar, Robert D. Inman, Stephen Xu, Michael Mack, Benjamin Hsu> ;Rheumatology. 2013 Feb 1
• 47 citations
  Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti–tumor necrosis factor antibody, in Phase II...
  Elizabeth C. Hsia, John J. Cush, Eric L. Matteson, A. Beutler, Mittie K. Doyle, Benjamin Hsu, Stephen Xu, Mahboob Rahman> ;Arthritis Care & Research. 2013 Feb 1
• 72 citations
  MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a t...
  Pedro Machado, Robert Landewé, Jürgen Braun, Xenofon Baraliakos, Kay-Geert A. Hermann, Benjamin Hsu, Daniel Baker, Désirée van der Heijde> ;Annals of the Rheumatic Diseases. 2012 Aug 1
• 72 citations
  Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti–tumor necrosis factor antibody, in patients with rheumatoid arth...
  Elizabeth C. Hsia, Neil W. Schluger, John J. Cush, Richard E. Chaisson, Eric L. Matteson, Stephen Xu, A. Beutler, Mittie K. Doyle, Benjamin Hsu, Mahboob Rahman> ;Arthritis and Rheumatism. 2012 Jul 1
• 83 citations
  Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study
  Jürgen Braun, Xenofon Baraliakos, Kay-Geert A. Hermann, Désirée van der Heijde, Robert D. Inman, Atul Deodhar, A. Baratelle, Stephen Xu, W. Xu, Benjamin Hsu> ;Annals of the Rheumatic Diseases. 2012 Jun 1
• 71 citations
  Extended report: Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
  Jürgen Braun, Atul Deodhar, Robert D. Inman, Désirée van der Heijde, Michael Mack, Stephen Xu, Benjamin Hsu> ;Annals of the Rheumatic Diseases. 2012 May 1
• 33 citations
  Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab
  Carrie Wagner, Sudha Visvanathan, Jürgen Braun, Désirée van der Heijde, Atul Deodhar, Benjamin Hsu, Michael Mack, Michael Elashoff, Robert D. Inman> ;Annals of the Rheumatic Diseases. 2012 May 1
• 105 citations
  MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis
  Désirée van der Heijde, Pedro Machado, Jürgen Braun, Kay-Geert A. Hermann, Xenofon Baraliakos, Benjamin Hsu, Daniel Baker, Robert Landewé> ;Annals of the Rheumatic Diseases. 2012 Mar 1
• 136 citations
  Predicting the outcome of ankylosing spondylitis therapy
  Nathan Vastesaeger, Désirée van der Heijde, Robert D. Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob Rahman, Ben A. C. Dijkmans, Piet Geusens, Bert Vander Cru...> ;Annals of the Rheumatic Diseases. 2011 Jun 1
• 46 citations
  Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trial
  Atul Deodhar, Jürgen Braun, Robert D. Inman, Michael Mack, S Parasuraman, Jacqueline Buchanan, Benjamin Hsu, Tim Gathany, Désirée van der Heijde> ;Arthritis Care & Research. 2010 Sep 1
• 425 citations
  Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.
  Robert D. Inman, John C. Davis, Désirée van der Heijde, Laura Diekman, Joachim Sieper, Sung-Il Kim, Michael Mack, J. Han, Sudha Visvanathan, Zhenhua Xu, Benjamin Hsu, ...> ;Arthritis and Rheumatism. 2008 Nov 1
• Join now to see all